A new synthesis of deoxynojirimycin (DNJ) analogues (galacto-and altrose con®guration) has been achieved through a functionalized cyclopentene derivative crafted from the norbornyl system, employing double reductive amination as the key step. The new DNJ analogues have been evaluated against various glycosidases and found to be moderate to strong inhibitors.
Natural and unnatural polyhydroxylated piperidines have aroused the widespread attention of organic chemists in recent years due to their very promising biological activity pro®le and synthetically challenging structural features present in them. 1 These polyhydroxylated piperidines generically termed as iminosugars (`azasugars'), closely resemble monosaccharides in terms of their shape and structure; they competitively inhibit glycosidases, enzymes responsible for the cleavage of glycosidic bonds. In azasugars, the ring oxygen is replaced by nitrogen, which can be protonated under physiological pH, thus mimicking the glycopyranosyl cation. Inhibition of glycosidases is projected to be useful in the treatment of carbohydrate related metabolic disorders and holds promise for the development of drugs for the treatment of cancer, diabetes, HIV and viral infections.
2 A large number of naturally occurring azasugars and their synthetically designed analogues are known, and nojirimycin 1, Recently we have developed a fragmentation reaction-based strategy to extract a highly functionalized and stereochemically well de®ned cyclopentene derivative 8 from the readily available norbornyl derivative 5 through the intermediacy of 6 and 7, respectively, Scheme 1.
5 Cyclopentane derivative 8 has now been further restructured to DNJ analogues 6 employing double reductive amination as the key step.
The free hydroxyl group in the iodocyclopentane 8 was transformed to a leaving group through mesylation to furnish the mesylate 9. Acetolysis of 9 led to elimination followed by allylic displacement to furnish acetoxycyclopentene 10, in which the ole®nic moiety was well positioned for further manipulation. OsO 4 -mediated catalytic dihydroxylation of 10 proceeded in a stereoselective manner to give 11 7 and 12 7 (10:90), Scheme 2. While diastereomers 11 and 12 were separated and characterized, it was not considered necessary for the next step. Sodium periodateinduced glycol cleavage in 11 and 12 furnished the labile keto-aldehyde 13 which was as such subjected to double-reductive amination in the NaCNBH 3 ±BnNH 2 milieu to furnish 14 as a mixture of two diastereomers (1:2) . Base mediated hydrolysis of the acetate group in 14 and chromatographic separation of the diastereomers led to 15 7 and 16, 7 which were fully characterized as having the altrose and galactose stereochemical disposition, 6 respectively, on the basis of incisive NMR (COSY, NOE) studies (Scheme 2).
In independent deprotection sequences, 15 and 16 were transformed to the hydrochlorides of N-benzyl DNJ derivatives 17 and 19, respectively, Scheme 3. In a similar manner, hydrochlorides of altro-deoxynojirimycin methyl ether 18 6 and galactostatin methyl ether 20 were obtained from 15 and 16, respectively, and duly characterized. Compounds 17±20 were assayed for their glycosidase inhibition activity (Table 1 ). All measurements were carried out with the corresponding nitrophenyl glycoside substrates in aqueous buer at appropriate pH. Galactostatin methyl ether 20 was found to be a selective and potent inhibitor of a-galactosidase and there was no inhibition observed for a-and b-glucosidases and b-galactosidase. It was notable that inhibitory activity of 20 was approximately 1000 fold less than of the natural product galactostatin 21. 6 When 20 was compared with its benzyl derivative 19, a marked decline in inhibitory activity as well as selectivity was observed and the latter was only a moderate inhibitor of a-galactosidase, and a weak inhibitor of a-glucosidase. Interestingly, 18 (C 2 -epimer of 20) was also found to be a selective inhibitor of a-galactosidase whereas its benzyl derivative was found to be essentially ineective towards glycosidase inhibition.
In short, we have devised a new synthesis of DNJ derivatives 17±20 from the cyclopentanoid building block 7. Our results of enzymatic assays reveal that N-and O-substituents have signi®cant consequence on the glycosidase activity and selectivity. 
